Søgeresultater - David I. Marks

Refine Results
  1. 1
    Management of adults with T-cell lymphoblastic leukemia

    Management of adults with T-cell lymphoblastic leukemia af David I. Marks, Clare Rowntree

    Udgivet 2017
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  2. 2
    Patient‐reported outcomes from a phase 3 randomized controlled trial of inotuzumab ozogamicin versus standard therapy for relapsed/refractory acute lymphoblastic leukemia

    Patient‐reported outcomes from a phase 3 randomized controlled trial of inotuzumab ozogamicin versus standard therapy for relapsed/refractory acute lymphoblastic leukemia af Hagop M. Kantarjian, Yun Su, Elias Jabbour, Helen Bhattacharyya, Eric Yan, Joseph C. Cappelleri, David I. Marks

    Udgivet 2018
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  3. 3
    Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chain reaction

    Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chain reaction af Emma Williamson, John P. Leeming, Helen Palmer, Colin G. Steward, David W. Warnock, David I. Marks, Michael Millar

    Udgivet 2000
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  4. 4
    The Solution Structure of a Transient Photoreceptor Intermediate: Δ25 Photoactive Yellow Protein

    The Solution Structure of a Transient Photoreceptor Intermediate: Δ25 Photoactive Yellow Protein af Cédric Bernard, Klaartje Houben, Nocky M. Derix, David I. Marks, Michael Horst, Klaas J. Hellingwerf, Rolf Boelens, Robert Kaptein, Nico A. J. van Nuland

    Udgivet 2005
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  5. 5
    Management of important adverse events associated with inotuzumab ozogamicin: expert panel review

    Management of important adverse events associated with inotuzumab ozogamicin: expert panel review af Partow Kebriaei, Corey Cutler, Marcos de Lima, Sergio Giralt, Stephanie J. Lee, David I. Marks, Akil Merchant, Wendy Stock, Koen van Besien, Matthias Stelljes

    Udgivet 2018
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  6. 6
    Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem‐cell transplantation

    Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem‐cell transplantation af David I. Marks, Antonio Pagliuca, Christopher C. Kibbler, Axel Glasmacher, Claus Peter Heußel, Michal Kantecki, Paul Miller, Patricia Ribaud, Haran T. Schlamm, Carlos Solano, Gordon Cook

    Udgivet 2011
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  7. 7
    Conditioning Chemotherapy Dose Adjustment in Obese Patients: A Review and Position Statement by the American Society for Blood and Marrow Transplantation Practice Guideline Committee

    Conditioning Chemotherapy Dose Adjustment in Obese Patients: A Review and Position Statement by the American Society for Blood and Marrow Transplantation Practice Guideline Committ... af Joseph Bubalo, Paul A. Carpenter, Navneet S. Majhail, Miguel‐Angel Perales, David I. Marks, Paul Shaughnessy, Joseph Pidala, Helen Leather, John R. Wingard, Bipin N. Savani

    Udgivet 2014
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  8. 8
    The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation

    The clinical features, risk factors and outcome of thrombotic thrombocytopenic purpura occurring after bone marrow transplantation af Rhian Fuge, Jennifer M. Bird, Anne Fraser, Dan Hart, Linda Hunt, Jacqueline Cornish, Nicholas Goulden, A Oakhill, Derwood Pamphilon, Colin G. Steward, David I. Marks

    Udgivet 2001
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  9. 9
    Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for Relapsed and Refractory Mantle Cell Lymphoma (MCL): A Study of the British Society for Blood and Marrow Transplantation

    Outcome following Reduced-Intensity Allogeneic Stem Cell Transplantation (RIC AlloSCT) for Relapsed and Refractory Mantle Cell Lymphoma (MCL): A Study of the British Society for Bl... af Gordon Cook, Graeme Smith, Keiren Kirkland, Jungwha Lee, Rachel Pearce, Kirsty Thomson, Emma Morris, Kim Orchard, Simon Rule, Nigel H. Russell, Charles Craddock, David I. Marks

    Udgivet 2010
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  10. 10
    Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study

    Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study af Julio Delgado, Kirsty Thomson, Nigel H. Russell, Joanne Ewing, Wendy A. Stewart, Gordon Cook, Stephen Devereux, Richard Lovell, Rajesh Chopra, David I. Marks, Stephen Mackinnon, Donald Milligan

    Udgivet 2005
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  11. 11
    Factors Influencing the Outcome of a Second Autologous Stem Cell Transplant (ASCT) in Relapsed Multiple Myeloma: A Study from the British Society of Blood and Marrow Transplantation Registry

    Factors Influencing the Outcome of a Second Autologous Stem Cell Transplant (ASCT) in Relapsed Multiple Myeloma: A Study from the British Society of Blood and Marrow Transplantatio... af Gordon Cook, Effie Liakopoulou, Rachel Pearce, Jim Cavet, Gareth J. Morgan, Keiren Kirkland, Julia Lee, Faith E. Davies, R. Hall, Amin Rahemtulla, Nigel H. Russell, David I. Marks

    Udgivet 2011
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  12. 12
    Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro

    Reduced cellularity of bone marrow in multiple sclerosis with decreased MSC expansion potential and premature ageing in vitro af Juliana Redondo, Pamela Sarkar, Kevin Kemp, Paul Virgo, Joya Pawade, Aimie Norton, David C. Emery, M.G. Guttridge, David I. Marks, Alastair Wilkins, Neil Scolding, Claire M Rice

    Udgivet 2017
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  13. 13
    A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease

    A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host Disease af Partow Kebriaei, Jack Hayes, Andrew Daly, Joseph P. Uberti, David I. Marks, Robert J. Soiffer, Edmund K. Waller, Elizabeth Burke, Donna Skerrett, Elizabeth J. Shpall, Paul J. Martin

    Udgivet 2019
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  14. 14
    Younger Matched Unrelated Donors Confer Decreased Relapse Risk Compared to Older Sibling Donors in Older Patients with B Cell Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation

    Younger Matched Unrelated Donors Confer Decreased Relapse Risk Compared to Older Sibling Donors in Older Patients with B Cell Acute Lymphoblastic Leukemia Undergoing Allogeneic Hem... af Muhammad Bilal Abid, Noel Estrada-Merly, Mei‐Jie Zhang, Karen Chen, Christopher Bredeson, David Allan, Mitchell Sabloff, David I. Marks, Mark R. Litzow, Christopher S. Hourigan, Partow Kebriaei, Wael Saber

    Udgivet 2023
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  15. 15
    Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia

    Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia af Judith Marsh, Vikas Gupta, ZiYi Lim, Aloysius Ho, Robin Ireland, Janet Hayden, Victoria Potter, Mickey Koh, M. Serajul Islam, Nigel H. Russell, David I. Marks, Ghulam J. Mufti, Antonio Pagliuca

    Udgivet 2011
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  16. 16
    Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden

    Inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: outcomes by disease burden af Daniel J. DeAngelo, Anjali S. Advani, David I. Marks, Matthias Stelljes, Michaela Liedtke, Wendy Stock, Nicola Gökbuget, Elias Jabbour, Akil Merchant, Tao Wang, Erik Vandendries, Alexander Neuhof, Hagop M. Kantarjian, Susan O’Brien

    Udgivet 2020
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  17. 17
    Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic Leukemia

    Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic Leukemia af David I. Marks, Partow Kebriaei, Matthias Stelljes, Nicola Gökbuget, Hagop M. Kantarjian, Anjali S. Advani, Akil Merchant, Wendy Stock, Ryan D. Cassaday, Tao Wang, Hui Zhang, Fausto R. Loberiza, Erik Vandendries, Daniel J. DeAngelo

    Udgivet 2019
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  18. 18
    Outcomes in older adults with acute lymphoblastic leukaemia (<scp>ALL</scp>): results from the international <scp>MRC UKALL XII</scp>/<scp>ECOG</scp>2993 trial

    Outcomes in older adults with acute lymphoblastic leukaemia (<scp>ALL</scp>): results from the international <scp>MRC UKALL XII</scp>/<scp>ECOG</scp>2993 trial af Jonathan Sive, Georgina Buck, Adele K. Fielding, Hillard M. Lazarus, Mark R. Litzow, Selina M. Luger, David I. Marks, Andrew McMillan, Anthony V. Moorman, Susan Richards, Jacob M. Rowe, Martin S. Tallman, Anthony H. Goldstone

    Udgivet 2012
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  19. 19
    Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients

    Systematic review and mixed treatment comparison meta-analysis of randomized clinical trials of primary oral antifungal prophylaxis in allogeneic hematopoietic cell transplant reci... af Eric J. Bow, David J. Vanness, Monica A. Slavin, Catherine Cordonnier, Oliver A. Cornely, David I. Marks, Antonio Pagliuca, Carlos Solano, Lael Cragin, A. Shaul, Sonja Sorensen, Richard Chambers, Michal Kantecki, David Weinstein, Haran T. Schlamm

    Udgivet 2015
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  20. 20
    Impact of immune modulation with anti–T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies

    Impact of immune modulation with anti–T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies af Robert J. Soiffer, Jennifer Le‐Rademacher, Vincent T. Ho, Fangyu Kan, Andrew Artz, Richard E. Champlin, Steven M. Devine, Luis Isola, Hillard M. Lazarus, David I. Marks, David Porter, Edmund K. Waller, Mary M. Horowitz, Mary Eapen

    Udgivet 2011
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: